HSBC initiated coverage on shares of Diploma (LON:DPLM) in a report released on Tuesday. The brokerage set a “hold” rating and a GBX 1,325 ($17.31) price target on the stock. HSBC’s target price would indicate a potential downside of 0.38% from the stock’s current price.
Several other equities analysts have also commented on DPLM. Peel Hunt reaffirmed an “add” rating on shares of Diploma in a research note on Monday. Berenberg Bank decreased their price target on Diploma from GBX 1,435 ($18.75) to GBX 1,350 ($17.64) and set a “hold” rating on the stock in a research note on Tuesday, January 29th. Royal Bank of Canada reaffirmed a “sector performer” rating and issued a GBX 1,280 ($16.73) price target on shares of Diploma in a research note on Monday, November 19th. Finally, Barclays upped their price target on Diploma from GBX 1,190 ($15.55) to GBX 1,225 ($16.01) and gave the company an “equal weight” rating in a research note on Tuesday, November 20th. Six analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of GBX 1,356.43 ($17.72).
Shares of LON:DPLM opened at GBX 1,330 ($17.38) on Tuesday. Diploma has a 52-week low of GBX 1,010 ($13.20) and a 52-week high of GBX 1,270 ($16.59).
Diploma (LON:DPLM) last announced its quarterly earnings results on Monday, November 19th. The company reported GBX 56.40 ($0.74) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of GBX 55.20 ($0.72) by GBX 1.20 ($0.02).
In other Diploma news, insider Nigel Lingwood purchased 3,000 shares of the firm’s stock in a transaction dated Friday, November 23rd. The shares were acquired at an average price of GBX 1,331 ($17.39) per share, with a total value of £39,930 ($52,175.62).
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through Life Sciences, Seals, and Controls business sectors. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; electrosurgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.
Read More: Stock Split
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.